Jing Lou

Dr. Jing Lou is a Chairman at Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd., a Chairman at Shenzhen Sciprogen Bio-Pharmaceutical Co., Ltd., a Chairman at Collected Mind Ltd., a Chairman at Taizhou Huan Sheng Investment Management Co., Ltd., a Chief Executive Officer, Executive Director & GM at Liaoning Sunshine Science & Technology Development Co. Ltd., a General Manager & Director at Liaoning Sunshine Bio-Pharmaceutical Co., Ltd., a Chairman & Director-Research & Development at Shenyang Sunshine Pharmaceutical Co., Ltd., a Chairman, President & Chief Executive Officer at 3SBio, Inc., a Chairman at Guangdong Sciprogen Bio-Pharmaceutical Technology Co., Ltd., a Chairman at Guangdong Sunshine Pharmaceutical Co., Ltd. and a Chairman at Shanghai Xingsheng Pharmaceutical Co., Ltd. He is on the Board of Directors at Ample Harvest Investments Ltd., Excel Partner Holdings Ltd., Shanghai Aoxi Technology Information Consulting Co., Ltd., Shenzhen Baishitong Technology Development Co., Ltd., Zhejiang Sunshine Pharmaceutical Co., Ltd., Hong Kong Sansheng Ltd., Hongkong Sansheng Medical Ltd., Liaoning Sunshine Science & Technology Development Co. Ltd., Liaoning Sunshine Bio-Pharmaceutical Co., Ltd. and Strategic International Group Ltd. Dr. Lou also served on the board at Isotechnika Pharma, Inc. He received his undergraduate degree from Shanghai Second Medical University, an MBA from China Europe International Business School and a doctorate degree from Fordham University.